VVOS: Vivos Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

Info & Links

CEO

R. Kirk Huntsman

Headquarters

7921 SOUTHPARK PLAZA, SUITE 210
LITTLETON, CO 80120, UNITED STATES

Auditor

Moss Adams, LLP

Share holders

7,309

Employees

114

Vivos Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

15.28M

Enterprise Value

8.97M

Enterprise Value/EBITDA(ttm)

-0.75

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.33

Price to Book(mrq)

2.05

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

61.71%

Operating Margin(ttm)

-86.19%

Profit Margin(ttm)

-89.14%

Return on Equity(ttm)

-335.04%

Return on Invested Capital(ttm)

-1747.35%

Return on Assets(ttm)

-93.58%

Income Statement

Revenue(ttm)

14.58M

Revenue Per Share(ttm)

3.02

Gross Profit(ttm)

9.01M

EBITDA(ttm)³

-11.91M

Net Income Available to Common(ttm)

-12.57M

Diluted EPS(ttm)

-5.68

Share Statistics

Beta (5Y Monthly)

7.47

52-Week Change

-33.54%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

4.84M

Dividend Yield

0.00%

Float⁴

5.71M

% Held by Insiders

3.00%

% Held by Institutions

26.35%

Balance Sheet

Total Cash(mrq)

6.31M

Total Cash Per Share(mrq)

1.31

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.44%

Quick Ratio(mrq)

1.44%

Book Value Per Share(mrq)

1.61

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.47

Free Cash Flow(ytd)

-10.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

VVOS

Vivos Therapeutics, Inc. Common Stock

Vivos Therapeutics, Inc. Common Stock Profile